146 related articles for article (PubMed ID: 35877137)
1. Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument.
Kasthuri RS; Chaturvedi S; Thomas S; Vandergrift N; Bann C; Schaefer N; Clancy MS; Pyeritz R; McCrae KR
Blood Adv; 2022 Jul; 6(14):4301-4309. PubMed ID: 35877137
[TBL] [Abstract][Full Text] [Related]
2. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia.
Merlo CA; Yin LX; Hoag JB; Mitchell SE; Reh DD
Int Forum Allergy Rhinol; 2014 Nov; 4(11):921-5. PubMed ID: 25145809
[TBL] [Abstract][Full Text] [Related]
3. Health-Related Quality of Life Outcome Measures in Individuals With Hereditary Hemorrhagic Telangiectasia: A Scoping Review.
Gong AJ; Garg T; Khalil A; Gowda PC; Mathai SC; Rowan NR; Merlo CA; Weiss CR
Am J Rhinol Allergy; 2024 Jan; 38(1):60-76. PubMed ID: 37855028
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of the Nasal Outcome Score for Epistaxis in Hereditary Hemorrhagic Telangiectasia (NOSE HHT).
Peterson AM; Kallogjeri D; Spitznagel E; Chakinala MM; Schneider JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):999-1005. PubMed ID: 33022056
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT.
Le TTT; Martinent G; Dupuis-Girod S; Parrot A; Contis A; Riviere S; Chinet T; Grobost V; Espitia O; Dussardier-Gilbert B; Alric L; Armengol G; Maillard H; Leguy-Seguin V; Leroy S; Rondeau-Lutz M; Lavigne C; Mohamed S; Chaussavoine L; Magro P; Seguier J; Kerjouan M; Fourdrinoy S
Orphanet J Rare Dis; 2022 Jul; 17(1):281. PubMed ID: 35854330
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT).
Zarrabeitia R; Fariñas-Álvarez C; Santibáñez M; Señaris B; Fontalba A; Botella LM; Parra JA
Health Qual Life Outcomes; 2017 Jan; 15(1):19. PubMed ID: 28114930
[TBL] [Abstract][Full Text] [Related]
7. Intranasal bevacizumab injections improve quality of life in HHT patients.
Steineger J; Geirdal AØ; Osnes T; Heimdal KR; Dheyauldeen S
Laryngoscope; 2020 May; 130(5):E284-E288. PubMed ID: 31287573
[TBL] [Abstract][Full Text] [Related]
8. Validation of epistaxis severity score for hereditary hemorrhagic telangiectasia in Japan.
Hayama M; Maeda Y; Shikina T; Tatehara S; Inokuchi G; Hoag JB; Sato T; Obata S; Nakatani A; Amano Y; Hida E; Nibu KI; Inohara H
Auris Nasus Larynx; 2022 Jun; 49(3):415-420. PubMed ID: 34857410
[TBL] [Abstract][Full Text] [Related]
9. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire.
Karapantzos I; Tsimpiris N; Goulis DG; Van Hoecke H; Van Cauwenberge P; Danielides V
Eur Arch Otorhinolaryngol; 2005 Oct; 262(10):830-3. PubMed ID: 15739086
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: a population based study.
Geirdal AØ; Dheyauldeen S; Bachmann-Harildstad G; Heimdal K
Am J Med Genet A; 2012 Jun; 158A(6):1269-78. PubMed ID: 22529055
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in hereditary hemorrhagic telangiectasia.
Geisthoff UW; Heckmann K; D'Amelio R; Grünewald S; Knöbber D; Falkai P; König J
Otolaryngol Head Neck Surg; 2007 May; 136(5):726-33; discussion 734-5. PubMed ID: 17478205
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Psychometric Validity of the Epistaxis Severity Score: Internal Consistency and Test-Retest Reliability.
Gong AJ; Bolsegui ML; Lee EE; Mathai SC; Weiss CR
Am J Rhinol Allergy; 2024 Jan; 38(1):38-46. PubMed ID: 37822162
[TBL] [Abstract][Full Text] [Related]
13. Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
Thiele B; Abdel-Aty Y; Marks L; Lal D; Marino M
Ann Otol Rhinol Laryngol; 2023 Jan; 132(1):82-90. PubMed ID: 35152768
[TBL] [Abstract][Full Text] [Related]
14. Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: A cross-sectional survey.
Chaturvedi S; Clancy M; Schaefer N; Oluwole O; McCrae KR
Thromb Res; 2017 May; 153():14-18. PubMed ID: 28314138
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
[TBL] [Abstract][Full Text] [Related]
16. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia.
Yin LX; Reh DD; Hoag JB; Mitchell SE; Mathai SC; Robinson GM; Merlo CA
Laryngoscope; 2016 May; 126(5):1029-32. PubMed ID: 26393959
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological, clinical and endoscopic features of epistaxis severity and quality of life in Hereditary haemorrhagic telangiectasia: a cross-sectional study.
Pagella F; Maiorano E; Ugolini S; Lizzio R; Sovardi F; Mirabella R; Nanfito L; Tinelli C; De Silvestri A; Olivieri C; Spinozzi G; Matti E
Rhinology; 2021 Dec; 59(6):577-584. PubMed ID: 34726201
[TBL] [Abstract][Full Text] [Related]
18. TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial.
Andorfer KEC; Seebauer CT; Koller M; Zeman F; Berneburg M; Fischer R; Vielsmeier V; Bohr C; Kühnel TS
Clin Hemorheol Microcirc; 2022; 80(3):307-315. PubMed ID: 34864649
[TBL] [Abstract][Full Text] [Related]
19. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
[TBL] [Abstract][Full Text] [Related]
20. A new endoscopic staging system for hereditary hemorrhagic telangiectasia.
Reh DD; Yin LX; Laaeq K; Merlo CA
Int Forum Allergy Rhinol; 2014 Aug; 4(8):635-9. PubMed ID: 24782401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
